Joaquin Garcia-Estrada

Dr. Joaquin Garcia-Estrada

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FCFernando Cruz-Mendoza
Fernando Cruz-Mendoza
FJFernando Jauregui
Fernando Jauregui
AAAdriana Aguilar-Delgadillo
Adriana Aguilar-Delgadillo
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
SLSonia Luquin
Sonia Luquin
The c-fos gene was first described as a proto-oncogene responsible for the induction of bone tumors. A few decades ago, activation of the protein product c-fos was reported in the brain after seizures and other noxious stimuli. Since then, multiple studies have used c-fos as a brain activity marker. Although it has been attributed to neurons, growing evidence demonstrates that c-fos expression in the brain may also include glial cells. In this review, we collect data showing that glial cells also express this proto-oncogene. We present evidence demonstrating that at least astrocytes, oligodendrocytes, and microglia express this immediate early gene (IEG). Unlike neurons, whose expression changes used to be associated with depolarization, glial cells seem to express the c-fos proto-oncogene under the influence of proliferation, differentiation, growth, inflammation, repair, damage, plasticity, and other conditions. The collected evidence provides a complementary view of c-fos as an activity marker and urges the introduction of the glial cell perspective into brain activity studies. This glial cell view may provide additional information related to the brain microenvironment that is difficult to obtain from the isolated neuron paradigm. Thus, it is highly recommended that detection techniques are improved in order to better differentiate the phenotypes expressing c-fos in the brain and to elucidate the specific roles of c-fos expression in glial cells.

1 August 2010 in Current Immunology Reviews
Verified
Journal Article
Closed access
PDF file
FJFernando Jauregui-Huerta
Fernando Jauregui-Huerta
YRYaveth Ruvalcaba-Delgadillo
Yaveth Ruvalcaba-Delgadillo
OGOscar Gonzalez-Perez
Oscar Gonzalez-Perez
RGRocio Gonzalez-Castaneda
Rocio Gonzalez-Castaneda
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
SLSonia Luquin
Sonia Luquin
A growing body of evidence suggests that glial cells are involved in practically all aspects of neural function. Glial cells regulate the homeostasis of the brain, influence the development of the nervous system, modulate synaptic activity, and carry out the immune response inside the brain. In addition, they play an important role in the restoration of the nervous system after damage, and they also participate in various neurodegenerative disorders. In a similar way, the importance of stress and glucocorticoids (GCs) on brain function is being increasingly recognized. Within the brain, stress hormones target both neurons and glial cells. Through their actions on these cells, glucocorticoids exert organizational functions on various processes of the developing brain and contribute to neuronal plasticity in the adult brain. Moreover, stress and glucocorticoids have become especially attractive in the study of a number of neurodegenerative disorders. However, studies on the mechanisms behind glucocorticoid-induced regulation of brain function have been classically focused on their effects on neurons. In this review, we start by describing the main functions of glial cells and then proceed to present data highlighting the effects of stress and GCs on brain function. We conclude the review by presenting recent evidence linking stress and glucocorticoids to glial cell function.

4 March 2025 in NeuroSci
Verified
Journal Article
Open access
PDF file
David Fernández-QuezadaDavid Fernández-Quezada
David Fernández-Quezada
DMDiana Emilia Martínez-Fernández
Diana Emilia Martínez-Fernández
IFIleana Fuentes
Ileana Fuentes
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
SLSonia Luquin
Sonia Luquin
Environmental noise has been repeatedly linked to negative effects on cognitive functioning among children and adolescents. This research sought to systematically assess studies investigating the relationship between noise exposure and cognitive outcomes in young individuals. Through a meta-analysis of eight primary studies published between 2001 and 2023, this study examined the effects of various noise types on cognitive performance across multiple domains in young populations. The findings reveal that noise exposure significantly impairs cognitive performance in children and adolescents, with a standardized mean difference (SMD) of –0.544 (95% CI: [−0.616, −0.472]), z = −14.85, p < 0.0001. These results underscore the profound impact of environmental noise on cognitive functioning in younger populations.

1 January 2015 in Noise and Health
Verified
Journal Article
Open access
PDF file
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
YRYaveth Ruvalcaba-Delgadillo
Yaveth Ruvalcaba-Delgadillo
SLSonia Luquín
Sonia Luquín
RRRodrigo Ramos-Zúñiga
Rodrigo Ramos-Zúñiga
AFAlfredo Feria-Velasco
Alfredo Feria-Velasco
FJFernando Jáuregui-Huerta
Fernando Jáuregui-Huerta
In this experiment, we evaluated the long-term effects of noise by assessing both astrocyte changes in medial prefrontal cortex (mPFC) and mPFC-related alternation/discrimination tasks. Twenty-one-day-old male rats were exposed during a period of 15 days to a standardized rats' audiogram-fitted adaptation of a human noisy environment. We measured serum corticosterone (CORT) levels at the end of the exposure and periodically registered body weight gain. In order to evaluate the long-term effects of this exposure, we assessed the rats' performance on the T-maze apparatus 3 months later. Astrocyte numbers and proliferative changes in mPFC were also evaluated at this stage. We found that environmental noise (EN) exposure significantly increased serum CORT levels and negatively affected the body weight gain curve. Accordingly, enduring effects of noise were demonstrated on mPFC. The ability to solve alternation/discrimination tasks was reduced, as well as the number of astroglial cells. We also found reduced cytogenesis among the mPFC areas evaluated. Our results support the idea that early exposure to environmental stressors may have long-lasting consequences affecting complex cognitive processes. These results also suggest that glial changes may become an important element behind the cognitive and morphological alterations accompanying the PFC changes seen in some stress-related pathologies.

10 April 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
SLSonia Luquin
Sonia Luquin
KPKaren Pesqueda-Cendejas
Karen Pesqueda-Cendejas
ARAdolfo Ruiz
Adolfo Ruiz
BCBertha Campos-López
Bertha Campos-López
Ulises De la Cruz-MossoUlises De la Cruz-Mosso
Ulises De la Cruz-Mosso
Substance use disorders (SUDs) are widely prevalent in many countries, with the highest rates observed in nicotine and alcohol use, followed by opioid and cannabis use disorders. Within the field of SUDs, nutrition has become an increasingly important area of focus in both epidemiology and public health, as malnutrition is frequently observed among individuals affected by these disorders. Research indicates that people with SUDs are more likely to experience malnutrition than the general population; however, this issue remains an often-overlooked consequence that can impact disease progression and recovery outcomes. SUDs disrupt brain metabolism, leading to changes in brain function and disturbances in glucose, protein, and lipid metabolism. Evidence shows that individuals with certain SUDs often suffer from poor nutritional status, marked by high sugar consumption and insufficient intake of key micronutrients like iron, as well as vitamins D, C, A, and B—likely due to prioritizing drug use over adequate food intake. Importantly, diet can alter the metabolism and effects of drugs, potentially amplifying or diminishing their impact. While nutrition should play a central role in SUD treatment and rehabilitation, current research—both in animal models and human studies—on the role and benefits of specific nutrients in this context remains limited. This literature review aims to synthesize the available findings on the impact of malnutrition in human and murine models of SUDs, with the goal of identifying which nutrients may provide the most support for treatment and recovery.

31 October 2024 in Brain Sciences
Verified
Journal Article
Open access
PDF file
DMDiana Emilia Martínez-Fernández
Diana Emilia Martínez-Fernández
David Fernández-QuezadaDavid Fernández-Quezada
David Fernández-Quezada
AGAndrea P. Garzón-Partida
Andrea P. Garzón-Partida
IGIrene Guadalupe Aguilar Garcia
Irene Guadalupe Aguilar Garcia
JGJoaquin Garcia-Estrada
Joaquin Garcia-Estrada
SLSonia Luquin
Sonia Luquin
Substance use disorder (SUD) significantly impacts public health, economics, and legal systems worldwide. Eye Movement Desensitization and Reprocessing (EMDR) was initially developed in the late 1980s as a therapeutic approach for post-traumatic stress disorder (PTSD), using bilateral stimulation to integrate traumatic memories with calming physiological responses. However, the effectiveness of EMDR in treating SUD remains unclear. This study aims to conduct a systematic review and meta-analysis of the impact of EMDR therapy on craving reduction in individuals with SUD. The search was conducted using databases such as PubMed and Web of Science, focusing on studies that measured craving and employed EMDR interventions. Both random and fixed effects models were used to pool effect sizes, utilizing an R software meta-package (R-4.4.1). The study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The results indicated a significant reduction in cravings among patients undergoing EMDR therapy. Specifically, under the fixed effect model, the standardized mean difference (SMD) was −0.866 with a 95% confidence interval ranging from −1.121 to −0.611 (z = −6.66, p < 0.0001). These findings may demonstrate the significant efficacy of EMDR therapy in decreasing cravings in people with SUD.